BETA

6 Amendments of Christel SCHALDEMOSE related to 2023/0053(COD)

Amendment 232 #
Proposal for a directive
Recital 19
(19) Proof of compliance with minimum standards of physical and mental fitness for driving by drivers of vehicles used for the transport of persons or goods should be provided when the driving licence is issued and periodically thereafter. Such regular control in accordance with national rules of compliance with minimum standards would contribute to the free movement of persons, avoid distortions of competition and better take into account the specific responsibility of drivers of such vehicles. Member States should be allowed to impose medical examinations as a guarantee of compliance with the minimum standards of physical and mental fitness for driving other power-driven vehicles. For reasons of transparency, such examinations should coincide with a renewal of driving licences. Member States should be allowed to contribute to the free movement of persons by altering certain restrictions on driving licences for people using new medical technologies, which minimizes or eliminates the risk connected to driving with their medical condition.
2023/09/26
Committee: TRAN
Amendment 234 #
Proposal for a directive
Recital 19 a (new)
(19a) Recent years new medical technologies have contributed to improve road safety. Technologies which minimize or eliminate the risk connected to driving with specific medical conditions have been introduced to the market and implemented among patients. Monitoring technologies, such as continuous glucose monitoring systems (CGM) for people with diabetes mellitus, allows persons to effectively and continuously controlling their medical conditions thus eliminating the risk to driving connected to their disease. Furthermore technologies like CGM systems are currently being developed and improved at a rapid pace ensuring a continuously improved control of medical conditions and thereby contributing to increase road safety.
2023/09/26
Committee: TRAN
Amendment 236 #
Proposal for a directive
Recital 19 b (new)
(19b) The European Parliament by resolution 2022/2901 has called on the Commission to review the relevant occupational health and safety legal framework and the road safety legislation to avoid further discrimination of people living with diabetes.
2023/09/26
Committee: TRAN
Amendment 762 #
Proposal for a directive
Annex III – point 10 – paragraph 2 a (new)
Continuous monitoring system‘ means a device that provides the person using it with continuous and precise knowledge of their blood glucose data at all times as well as an alarm system issuing a warning in due time before an incident of hypoglycaemia is like to occur, thus enabling the person to avoid hypoglycemia.
2023/09/25
Committee: TRAN
Amendment 763 #
Proposal for a directive
Annex III – point 10 – paragraph 3 – point 1
(1) Driving licences may be issued to, or renewed for, applicants or drivers who have diabetes mellitus. When treated with medication, they shallwhich does not carry a risk of inducing hypoglycaemia, they should be subject to the normal procedure of obtaining a driving licence as defined by article 10 of this directive and thus be subject to authorised medical opinion and regular medical review, appropriate to each case, but the interval shall not exceed tfifteen years. Applicants or drivers who have diabetes mellitus and who are treated with medication which carries a risk of inducing hypoglycaemia should be subject to authorized medical opinion and regular medical review, appropriate to each case, and the interval shall not exceed ten years. National authorities may prolong the interval to fifteen years for applicants using a continuous glucose monitoring system, which allows the person to monitor the level of blood glucose precisely and continuously.
2023/09/25
Committee: TRAN
Amendment 764 #
Proposal for a directive
Annex III – point 10 – paragraph 7 – point 3 – paragraph 2
Moreover, in those cases, such licences shall be issued subject to the opinion of a competent medical authority and to regular medical review, undertaken at intervals of not more than three years. National authorities may prolong the interval to five years for applicants using a continuous glucose monitoring system, which allows the person to monitor the level of blood glucose precisely and continuously.
2023/09/25
Committee: TRAN